{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:02:32Z","timestamp":1781938952430,"version":"3.54.5"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.mehy.2009.11.028","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T09:08:18Z","timestamp":1261472898000},"page":"862-867","source":"Crossref","is-referenced-by-count":65,"title":["Glutamatergic modulatory therapy for Tourette syndrome"],"prefix":"10.1016","volume":"74","author":[{"given":"Harvey S.","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Grados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2009.11.028_bib1","doi-asserted-by":"crossref","unstructured":"The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993;50(10):1013-1016.","DOI":"10.1001\/archneur.1993.00540100012008"},{"issue":"8","key":"10.1016\/j.mehy.2009.11.028_bib2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.57.8.1383","article-title":"Prevalence of tics in school children and association with placement in special education","volume":"57","author":"Kurlan","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3999(02)00580-9","article-title":"Diagnosing Tourette syndrome: is it a common disorder?","volume":"55","author":"Robertson","year":"2003","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1016\/j.mehy.2009.11.028_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1469-8749.2003.tb00402.x","article-title":"Prevalence of tic disorders and Tourette syndrome in a Swedish school population","volume":"45","author":"Khalifa","year":"2003","journal-title":"Dev Med Child Neurol"},{"issue":"1 Pt. 1","key":"10.1016\/j.mehy.2009.11.028_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.102.1.14","article-title":"Course of tic severity in Tourette syndrome: the first two decades","volume":"102","author":"Leckman","year":"1998","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpedi.160.1.65","article-title":"Adulthood outcome of tic and obsessive\u2013compulsive symptom severity in children with Tourette syndrome","volume":"160","author":"Bloch","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib7","first-page":"307","article-title":"The neocortex. An overview of its evolutionary development, structural organization and synaptology","volume":"190","author":"Nieuwenhuys","year":"1994","journal-title":"Anat Embryol (Berl)"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0896-6273(91)90373-8","article-title":"Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor","volume":"7","author":"Clements","year":"1991","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.mehy.2009.11.028_bib9","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1523\/JNEUROSCI.18-12-04588.1998","article-title":"Dopamine neurons make glutamatergic synapses in vitro","volume":"18","author":"Sulzer","year":"1998","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(90)90535-J","article-title":"Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain","volume":"507","author":"Kaneko","year":"1990","journal-title":"Brain Res"},{"issue":"6579","key":"10.1016\/j.mehy.2009.11.028_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/381245a0","article-title":"Localization of dopamine D4 receptors in GABAergic neurons of the primate brain","volume":"381","author":"Mrzljak","year":"1996","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mehy.2009.11.028_bib12","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1073\/pnas.91.12.5720","article-title":"D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines","volume":"91","author":"Smiley","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0361-9230(00)00353-1","article-title":"Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat","volume":"53","author":"Del Arco","year":"2000","journal-title":"Brain Res Bull"},{"issue":"10","key":"10.1016\/j.mehy.2009.11.028_bib14","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1523\/JNEUROSCI.21-10-03628.2001","article-title":"Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons","volume":"21","author":"Seamans","year":"2001","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.mehy.2009.11.028_bib15","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1152\/jn.00335.2002","article-title":"Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex","volume":"88","author":"Gorelova","year":"2002","journal-title":"J Neurophysiol"},{"issue":"2","key":"10.1016\/j.mehy.2009.11.028_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0893-133X(98)00112-2","article-title":"Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex","volume":"21","author":"Yang","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1073\/pnas.011518798","article-title":"Dopamine D1\/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons","volume":"98","author":"Seamans","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.mehy.2009.11.028_bib18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0006-3223(99)00117-1","article-title":"Neurotransmitter interactions in schizophrenia\u2013therapeutic implications","volume":"46","author":"Carlsson","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.mehy.2009.11.028_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(00)00976-8","article-title":"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia","volume":"48","author":"Kegeles","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1471-4159.2001.00499.x","article-title":"Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens","volume":"78","author":"Jackson","year":"2001","journal-title":"J Neurochem"},{"issue":"5 Pt. 2","key":"10.1016\/j.mehy.2009.11.028_bib21","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.15-05-03896.1995","article-title":"Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors","volume":"15","author":"Taber","year":"1995","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.11.028_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(93)90483-2","article-title":"Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats","volume":"152","author":"Daly","year":"1993","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(94)90611-4","article-title":"Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid","volume":"256","author":"Morari","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/syn.890240102","article-title":"Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices","volume":"24","author":"Levine","year":"1996","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.mehy.2009.11.028_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.0953-816x.2001.01485.x","article-title":"Dopaminergic control of synaptic plasticity in the dorsal striatum","volume":"13","author":"Centonze","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2009.11.028_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.neuro.23.1.185","article-title":"Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens","volume":"23","author":"Nicola","year":"2000","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000017294","article-title":"Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum","volume":"20","author":"Cepeda","year":"1998","journal-title":"Dev Neurosci"},{"issue":"2","key":"10.1016\/j.mehy.2009.11.028_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/jn.2001.85.2.659","article-title":"Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice","volume":"85","author":"Cepeda","year":"2001","journal-title":"J Neurophysiol"},{"issue":"10 Suppl","key":"10.1016\/j.mehy.2009.11.028_bib29","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S1471-1931(00)00020-3","article-title":"Dopamine-mediated regulation of striatal neuronal and network interactions","volume":"23","author":"Onn","year":"2000","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1523\/JNEUROSCI.22-01-00294.2002","article-title":"Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis","volume":"22","author":"West","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1471-4159.2002.01169.x","article-title":"Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors","volume":"83","author":"Marti","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2009.11.028_bib32","series-title":"Neurobiology of disease","article-title":"Circuits to synapses: The pathophysiology of tourette syndrome","author":"Singer","year":"2006"},{"issue":"7","key":"10.1016\/j.mehy.2009.11.028_bib33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00415-003-1102-4","article-title":"Pathophysiology of tics and Tourette syndrome","volume":"250","author":"Berardelli","year":"2003","journal-title":"J Neurol"},{"issue":"7\u20138","key":"10.1016\/j.mehy.2009.11.028_bib34","first-page":"886","article-title":"Neurobiology and neuroimmunology of Tourette\u2019s syndrome: an update","volume":"61","author":"Hoekstra","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl.","key":"10.1016\/j.mehy.2009.11.028_bib35","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0387-7604(03)90012-X","article-title":"Neurobiology of Tourette syndrome: concepts of neuroanatomical localization and neurochemical abnormalities","volume":"25","author":"Singer","year":"2003","journal-title":"Brain and Development"},{"issue":"5","key":"10.1016\/j.mehy.2009.11.028_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: effects of stimulant and dose","volume":"36","author":"Castellanos","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.mehy.2009.11.028_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/08830738060210080901","article-title":"Tic Disorders: Neural Circuits, Neurochemistry, and Neuroimmunology","volume":"21","author":"Harris","year":"2006","journal-title":"J Child Neurology"},{"issue":"8","key":"10.1016\/j.mehy.2009.11.028_bib38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","article-title":"Elevated intrasynaptic dopamine release in Tourette\u2019s syndrome measured by PET","volume":"159","author":"Singer","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.mehy.2009.11.028_bib39","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-005-0092-6","article-title":"Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man","volume":"182","author":"Aalto","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.11.028_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2003.12.006","article-title":"Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum","volume":"219","author":"Minzer","year":"2004","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.11.028_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2007.01.069","article-title":"Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis","volume":"255","author":"Yoon","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2009.11.028_bib43","first-page":"123","article-title":"Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome","volume":"58","author":"Anderson","year":"1992","journal-title":"Adv Neurol"},{"issue":"7","key":"10.1016\/j.mehy.2009.11.028_bib44","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archpsyc.1992.01820070078016","article-title":"Brain monoamines and amino acids in Gilles de la Tourette\u2019s syndrome: a preliminary study of subcortical regions","volume":"49","author":"Anderson","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E","article-title":"Genome scan for linkage to Gilles de la Tourette syndrome","volume":"88","author":"Barr","year":"1999","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.mehy.2009.11.028_bib46","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ajmg.b.30654","article-title":"Association study for genes at chromosome 5p13\u2013q11 in attention deficit hyperactivity disorder","volume":"147B","author":"Laurin","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.mehy.2009.11.028_bib47","doi-asserted-by":"crossref","unstructured":"TSAICG. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007;80(2):265-272.","DOI":"10.1086\/511052"},{"key":"10.1016\/j.mehy.2009.11.028_bib48","unstructured":"Adamczyk A, Gause CD, Sattler R, et al. A functional missense variant in a glutamate transporter, EAAT1, in Tourette syndrome, submitted for publication ."},{"issue":"9","key":"10.1016\/j.mehy.2009.11.028_bib49","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.mehy.2009.11.028_bib50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.63.7.769","article-title":"Glutamate transporter gene SLC1A1 associated with obsessive\u2013compulsive disorder","volume":"63","author":"Arnold","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"10.1016\/j.mehy.2009.11.028_bib51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","article-title":"Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive\u2013compulsive disorder","volume":"63","author":"Dickel","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2009.11.028_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.b.31001","article-title":"A screen of SLC1A1 for OCD-related alleles","author":"Wang","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib53","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.2006.03978.x","article-title":"The neuronal excitatory amino acid transporter EAAC1\/EAAT3: does it represent a major actor at the brain excitatory synapse?","volume":"98","author":"Nieoullon","year":"2006","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib54","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-004-1847-1","article-title":"Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive\u2013compulsive disorder: a preliminary study","volume":"174","author":"Arnold","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.mehy.2009.11.028_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pscychresns.2009.02.005","article-title":"Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive\u2013compulsive disorder","volume":"172","author":"Arnold","year":"2009","journal-title":"Psychiatry Res"},{"issue":"24","key":"10.1016\/j.mehy.2009.11.028_bib56","doi-asserted-by":"crossref","first-page":"17594","DOI":"10.1074\/jbc.M702278200","article-title":"N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1","volume":"282","author":"Waxman","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nurx.2005.12.006","article-title":"Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive\u2013compulsive disorder","volume":"3","author":"Pittenger","year":"2006","journal-title":"NeuroRx"},{"issue":"5","key":"10.1016\/j.mehy.2009.11.028_bib58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive\u2013compulsive disorder: an open-label trial","volume":"58","author":"Coric","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.mehy.2009.11.028_bib59","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.v66n1121d","article-title":"Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder","volume":"66","author":"Pittenger","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.mehy.2009.11.028_bib60","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900010403","article-title":"Beyond monoamines: glutamatergic function in mood disorders","volume":"10","author":"Kugaya","year":"2005","journal-title":"CNS Spectr"},{"issue":"12","key":"10.1016\/j.mehy.2009.11.028_bib61","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1176\/appi.ajp.162.12.2379","article-title":"Open-label trial of riluzole in generalized anxiety disorder","volume":"162","author":"Mathew","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"21","key":"10.1016\/j.mehy.2009.11.028_bib62","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/138161206777698693","article-title":"Pharmacological management of Huntington\u2019s disease: an evidence-based review","volume":"12","author":"Bonelli","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2006.08.036","article-title":"Evaluation of clinically relevant glutamate pathway inhibitors in in vitro model of Huntington\u2019s disease","volume":"407","author":"Wu","year":"2006","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.mehy.2009.11.028_bib64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/cap.2007.0021","article-title":"An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive\u2013compulsive disorder","volume":"17","author":"Grant","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2009.11.028_bib65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00213-003-1396-z","article-title":"Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive\u2013compulsive disorder and major depressive disorder","volume":"167","author":"Coric","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib66","first-page":"81","article-title":"Differential Efficacy of Memantine for Obsessive\u2013Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial","volume":"42","author":"Feusner","year":"2009","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.mehy.2009.11.028_bib67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/bjp.152.3.383","article-title":"The psychopathology of the Gilles de la Tourette syndrome","volume":"152","author":"Robertson","year":"1988","journal-title":"A phenomenological analysis. Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2009.11.028_bib68","first-page":"468","article-title":"Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification","volume":"12","author":"Javitt","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"11","key":"10.1016\/j.mehy.2009.11.028_bib69","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.mehy.2009.11.028_bib70","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pharmthera.2008.08.004","article-title":"Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia","volume":"120","author":"Yang","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.mehy.2009.11.028_bib72","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4088\/JCP.v63n0708","article-title":"A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients","volume":"63","author":"Javitt","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with D-cycloserine for obsessive\u2013compulsive disorder","volume":"165","author":"Wilhelm","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.mehy.2009.11.028_bib74","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmented exposure therapy for obsessive\u2013compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"27","key":"10.1016\/j.mehy.2009.11.028_bib75","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2174\/138161205774414538","article-title":"Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis","volume":"11","author":"de Bartolomeis","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.mehy.2009.11.028_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuroscience.2008.01.071","article-title":"Regulation of N-methyl-d-aspartate receptors by astrocytic D-serine","volume":"158","author":"Oliet","year":"2009","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.mehy.2009.11.028_bib77","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.biopsych.2006.07.025","article-title":"A genetic variant of the serine racemase gene is associated with schizophrenia","volume":"61","author":"Morita","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2009.11.028_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s00726-006-0481-0","article-title":"D-serine: a new word in the glutamatergic neuro-glial language","author":"Scolari","year":"2007","journal-title":"Amino Acids"},{"issue":"5B","key":"10.1016\/j.mehy.2009.11.028_bib79","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/j.1582-4934.2008.00315.x","article-title":"D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain","volume":"12","author":"Billard","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.mehy.2009.11.028_bib80","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1139\/Y07-040","article-title":"d-Serine inhibits AMPA receptor-mediated current in rat hippocampal neurons","volume":"85","author":"Gong","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"10.1016\/j.mehy.2009.11.028_bib81","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.mehy.2009.11.028_bib82","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2004.12.037","article-title":"D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia","volume":"57","author":"Heresco-Levy","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2009.11.028_bib83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/ebmh.8.3.82","article-title":"Glycine and D-serine improve the negative symptoms of schizophrenia","volume":"8","author":"Stip","year":"2005","journal-title":"Evid Based Ment Health"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709007853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709007853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T23:47:20Z","timestamp":1685231240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709007853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0306987709007853"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.11.028","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}